Latest Ratings for ZWS Date Firm Action From To Feb 2022 Baird Upgrades Neutral Outperform Dec 2021 Mizuho Initiates Coverage On Buy Dec 2021 Oppenheimer Maintains Outperform View More Analyst Ratings for ZWS View the Latest Analyst Ratings read more
Google unveils AI prototype Mariner, using Gemini 2.0 technology to automate tasks and follow complex instructions. Available to select users. read more
Super Micro faces potential delisting from Nasdaq 100 Index due to underperformance and auditing scandal. Uncertainty surrounds its future. read more
Lowe’s introduces a standardized framework for generative AI, launched a product marketplace, relaunching a loyalty program, and reaffirming outlook.Lowe’s introduces AI framework, launches product marketplace, relaunches loyalty program, reaffirms outlook in investor conference. Latest Ratings for LOW Date Firm Action From To Feb 2022 Telsey Advisory Group Maintains Outperform Feb 2022 OTR Global Upgrades Mixed…
AstraZeneca and Merck report Lynparza’s significant survival benefits in high-risk breast cancer and Keytruda combo results in ovarian cancer. read more
AnaptysBio discontinues ANB032 for atopic dermatitis after a trial failure, refocusing on autoimmune assets with upcoming trial results in 2025-2026. read more
BofA Securities analyst initiates coverage on California Water with a Buy rating and $57 price target, highlighting its 17% upside potential and status as the cheapest US water utility amid strong competition and growing capital plans. Latest Ratings for CWT Date Firm Action From To Jan 2022 Seaport Global Upgrades Sell Neutral Dec 2021 Wells…
Latest Ratings for EPRT Date Firm Action From To Mar 2022 Raymond James Maintains Outperform Jan 2022 B of A Securities Downgrades Buy Neutral Jan 2022 Mizuho Downgrades Buy Neutral View More Analyst Ratings for EPRT View the Latest Analyst Ratings read more
Latest Ratings for MHK Date Firm Action From To Feb 2022 Barclays Maintains Equal-Weight Feb 2022 Raymond James Maintains Strong Buy Jan 2022 UBS Initiates Coverage On Neutral View More Analyst Ratings for MHK View the Latest Analyst Ratings read more